CEL SCI CORP — Director's Dealing 2020

Apr 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CEL SCI CORP (CVM)
CIK: 0000725363
Period of Report: 2020-04-20

Reporting Person: ZIMMERMAN DANIEL H (Senior Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-20	Options	$10.93	A	160000	Acquired	2030-04-19	Common Stock (160000)	Direct

Footnotes

F1: These stock options are performance based. Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.93 per share. The stock options vest upon the achievement of the following performance goals: i) 25% of the options will vest when the closing price of the Company's common stock exceeds $20.00 for ten consecutive trading days; ii) 50% of the options will vest when the closing price of the Company's common stock exceeds $25.00 for ten consecutive trading days; iii) 75% of the options will vest when the closing price of the Company's common stock exceeds $30.00 for ten consecutive trading days; and iv) 100% of the options will vest when either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia or (b) the closing price of the Company's common stock exceeds $40.00 for ten consecutive trading days.